Sasine JP - Search Results

1

Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias.

Tabbara N, Sharp J, Gaut D, Pham TTD, Tang K, Oliai C, Sim MS, Schiller G, Young P, Sasine JP. Tabbara N, et al. Among authors: sasine jp. Am J Hematol. 2022 Jul;97(7):E249-E255. doi: 10.1002/ajh.26551. Epub 2022 Apr 11. Am J Hematol. 2022. PMID: 35358346 Free article. No abstract available.

2

Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: novel agents and approaches currently in clinical trials.

Sasine JP, Schiller GJ. Sasine JP, et al. Blood Rev. 2015 Jan;29(1):1-9. doi: 10.1016/j.blre.2014.07.002. Epub 2014 Jul 16. Blood Rev. 2015. PMID: 25441922 Review.

3

Acute Myeloid Leukemia: How Do We Measure Success?

Sasine JP, Schiller GJ. Sasine JP, et al. Curr Hematol Malig Rep. 2016 Dec;11(6):528-536. doi: 10.1007/s11899-016-0346-x. Curr Hematol Malig Rep. 2016. PMID: 27604228 Review.

4

Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature.

Gaut D, Sasine J, Schiller G. Gaut D, et al. Leuk Res Rep. 2018 Apr 16;9:65-71. doi: 10.1016/j.lrr.2018.04.005. eCollection 2018. Leuk Res Rep. 2018. PMID: 29892552 Free PMC article.

5

B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma.

Gaut D, Bejjani A, Sasine J, Schiller G. Gaut D, et al. Hematol Rep. 2019 Jun 14;11(2):8100. doi: 10.4081/hr.2019.8100. eCollection 2019 May 23. Hematol Rep. 2019. PMID: 31285810 Free PMC article.

6

Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling.

Himburg HA, Roos M, Fang T, Zhang Y, Termini CM, Schlussel L, Kim M, Pang A, Kan J, Zhao L, Suh H, Sasine JP, Sapparapu G, Bowers PM, Schiller G, Chute JP. Himburg HA, et al. Among authors: sasine jp. J Clin Invest. 2020 Jan 2;130(1):315-328. doi: 10.1172/JCI129061. J Clin Invest. 2020. PMID: 31613796 Free PMC article.

7

Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience.

Gaut D, Burkenroad A, Duong T, Feammelli J, Sasine J, Schiller G. Gaut D, et al. Leuk Res. 2020 Mar;90:106314. doi: 10.1016/j.leukres.2020.106314. Epub 2020 Jan 30. Leuk Res. 2020. PMID: 32035355

8

Filgrastim associations with CAR T-cell therapy.

Gaut D, Tang K, Sim MS, Duong T, Young P, Sasine J. Gaut D, et al. Int J Cancer. 2021 Mar 1;148(5):1192-1196. doi: 10.1002/ijc.33356. Epub 2020 Nov 6. Int J Cancer. 2021. PMID: 33091961 Free PMC article.

9

Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis.

Reinhardt B, Lee P, Sasine JP. Reinhardt B, et al. Among authors: sasine jp. Cells. 2023 Feb 7;12(4):531. doi: 10.3390/cells12040531. Cells. 2023. PMID: 36831198 Free PMC article. Review.

10

Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.

Sasine JP, Kozlova NY, Valicente L, Dukov J, Tran DH, Himburg HA, Kumar S, Khorsandi S, Chan A, Grohe S, Li M, Kan J, Sehl ME, Schiller GJ, Reinhardt B, Singh BK, Ho R, Yue P, Pasquale EB, Chute JP. Sasine JP, et al. Cancer Res. 2024 Mar 15;84(6):919-934. doi: 10.1158/0008-5472.CAN-23-1950. Cancer Res. 2024. PMID: 38231476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters